ICML 2017 | Reducing the risk of secondary malignancies in lymphoma
David Hodgson
• 14 Jun 2017
David Hodgson, MD, MPH, FRCPC from the University of Toronto, Toronto, Canada discusses his presentation on ‘Strategies to reduce the risk of second malignancies” in lymphoma, presented at the International Conference on Malignant Lymphoma (ICML) 2017 held in Lugano, Switzerland. Comparing high-risk and low-risk lymphoma patients, Prof. Hodgson explains the importance of understanding when the risk of secondary malignancies, following radiation therapy, is a clinical priority. Prof. Hodgson goes on to describe the limitations of PET in identifying patients who require additional radiation therapy and the techniques that can be introduced to reduce radiation exposure to off-target tissues.
